Literature DB >> 34173261

Mimicking partial to total placental insufficiency in a rabbit model of cerebral palsy.

Zhongjie Shi1, Kehuan Luo1, Sanket Jani2, Melissa February2, Nithi Fernandes2, Neha Venkatesh3, Nadiya Sharif3, Sidhartha Tan1,2.   

Abstract

All placental abruptions begin as partial abruptions, which sometimes manifest as fetal bradycardia. The progression from partial to total abruption was mimicked by a new rabbit model of placental insufficiency, and we compared it, with sufficient statistical power, with the previous model mimicking total placental abruption. The previous model uses total uterine ischemia at E22 or E25 (70% or 79% term, respectively), in pregnant New Zealand white rabbits for 40 min (Full H-I). The new model, Partial+Full H-I, added a 30-min partial ischemia before the 40-min total ischemia. Fetuses were delivered either at E31.5 (full term) vaginally for neurobehavior testing, or by C-section at E25 for ex vivo brain cell viability evaluation. The onset of fetal bradycardia was within the first 2 min of either H-I protocol. There was no difference between Full H-I (n = 442 for E22, 312 for E25) and Partial+Full H-I (n = 154 and 80) groups in death or severely affected kits at E22 (76% vs. 79%) or at E25 (66% vs. 64%), or normal kits at E22 or E25, or any of the individual newborn neurobehavioral tests at any age. No sex differences were found. Partial+Full H-I (n = 6) showed less cell viability than Full H-I (n = 8) at 72-hr ex vivo in the brain regions studied. Partial+Full H-I insult produced similar cerebral palsy phenotype as our previous Full H-I model in a sufficiently powered study and may be more suitable for testing of potential neuroprotectants.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  fetus; hypoxia; infant; newborn; placental abruption

Year:  2021        PMID: 34173261      PMCID: PMC8709884          DOI: 10.1002/jnr.24901

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.433


  8 in total

1.  Enhanced nociceptive behavior and expansion of associated primary afferents in a rabbit model of cerebral palsy.

Authors:  Emily J Reedich; Landon T Genry; Meredith A Singer; Clarissa Fantin Cavarsan; Elvia Mena Avila; Daphne M Boudreau; Michael C Brennan; Alyssa M Garrett; Lisa Dowaliby; Megan R Detloff; Katharina A Quinlan
Journal:  J Neurosci Res       Date:  2022-07-15       Impact factor: 4.433

Review 2.  Experimental Models for Testing the Efficacy of Pharmacological Treatments for Neonatal Hypoxic-Ischemic Encephalopathy.

Authors:  Elisa Landucci; Domenico E Pellegrini-Giampietro; Fabrizio Facchinetti
Journal:  Biomedicines       Date:  2022-04-19

3.  Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma.

Authors:  Jun Zhang; Xiaojian Xu; Zongxin Chen; Zhengyu Zhu; Jianquan Hou
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-10       Impact factor: 2.650

4.  A Retrospective Study of Chemotherapy and 3D-Image-Guided Afterloading Intracavitary Radiotherapy in Locally Advanced Cervical Cancer.

Authors:  Xiaojun Li; Cunlian An; Chunlan Feng; Jieren Sun; Huixiang Lu; Xiaodong Yang; Kaiping Wang; Ruimei Wang
Journal:  J Oncol       Date:  2022-09-30       Impact factor: 4.501

5.  Carbetocin Controls Intraoperative Blood Loss and Thickness of Myometrium in Scar Uterus Cases.

Authors:  Dongjing Sun
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-04       Impact factor: 2.650

6.  Efficacy Evaluation of High-Volume Hemofiltration in Patients with Severe Acute Respiratory Distress Syndrome.

Authors:  Yonglei Zhang; Yan Zhang; Jiming Pan
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-20       Impact factor: 2.650

7.  miR-28-5p's Targeting of GAGE12I Inhibits Proliferation, Migration, and Invasion of Gastric Cancer in Vitro.

Authors:  Ruizhe Xu; Qi Guo; Peifeng Zhao; Haiyan Lu; Bo Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-30       Impact factor: 2.650

8.  Clinical Application of Multi-Index Combined Risk Assessment in Early Pregnancy for Screening of Preeclampsia.

Authors:  Xiaohong Xu; Guoxiu Yan; Jijun Liu; Xuelei Li; Bin Zhang; Xianglian Meng; Hongbo Chen; Baoliang Han; Kun Shao; Xuefen Zhao; Jing Liu; Yan Yan
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-27       Impact factor: 2.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.